The largest database of trusted experimental protocols

Spss statistic version 25

Manufactured by IBM
Sourced in United States

SPSS Statistics version 25 is a comprehensive statistical software package developed by IBM. It offers a wide range of analytical tools and techniques for data management, visualization, and statistical analysis. The software is designed to help organizations and researchers gain insights from their data, support decision-making, and drive informed conclusions.

Automatically generated - may contain errors

Lab products found in correlation

26 protocols using spss statistic version 25

1

Factors Associated with Health Literacy Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quantitative data are expressed as medians with interquartile ranges (IQR). Categorical variables are given as frequencies and percentages, respectively. First, the correlation of demographic and clinical variables with the raw scores of the sub-scales of the HLQ were assessed by means of univariable analyses. Correlation analyses were conducted using Spearman’s rank correlation and point-biserial correlation. Variables with p <0.1 in the univariable analysis were subsequently considered in a multivariable linear regression model for each sub-scale. To reliably identify factors being associated with poorer health literacy, the final multivariable models were built based on a stepwise variable selection procedure for each scale. Only patients with complete datasets were included into the respective analyses.
Our complete data analysis is exploratory. Hence, no adjustments for multiple testing were performed. For all tests we used a 0.05 level to define statistically relevant deviations from the respective null hypothesis. However, due to the large number of tests, p-values should be interpreted with caution. Data were analysed using IBM SPSS Statistic Version 25.0 (Armonk, NY: IBM Corp.). Figure was drawn with GraphPad Prism Version 8.0.2 (GraphPad Software, California, US).
+ Open protocol
+ Expand
2

Nonparametric Analysis of Infant Dietary Supplements

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis was performed with SPSS Statistic version 25.0 (IBM Company, Armonk, NY; USA). Some variables in this study did not follow a normal distribution. Since the sample size was small (21 infants), we considered it more appropriate to use nonparametric methods. Therefore, quantitative variables were expressed as medians and interquartile ranges (IQRs), and qualitative variables were expressed as a relative frequency and sample size (n). The U Mann–Whitney test was used to analyze differences in the variables according to diet supplementation, and Spearman’s rho correlations (r) were used to determine the association between variables. Statistical significance was defined as p < 0.05.
+ Open protocol
+ Expand
3

Statistical Analysis of Research Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Percentages were used for categorical data. The mean and standard deviation were used for continuous data after the normality assumption was validated, and a paired t-test was used in the analysis. Characteristics of the data between groups were analyzed by analysis of variance (ANOVA). The correlation of the data was measured using Pearson correlation coefficients. An r value of more than 0.3 or less than −0.3 confirmed a statistical correlation [20 (link)], and a p value of less than 0.05 indicated statistical significance. Interobserver reliability testing was performed using the Intraclass Correlation Coefficient (ICC). All statistical calculations were performed on IBM SPSS Statistic version 25.0 (IBM Corporation, Armonk, NY, USA).
+ Open protocol
+ Expand
4

Peritoneal Cytology Conversion Rate

Check if the same lab product or an alternative is used in the 5 most similar protocols
Assuming a rate of positive peritoneal cytology conversion of 6% during the course of surgery, with an alpha error of 0.05 and a statistical power of 85%, the estimated sample size was 120 patients. Statistical calculations were performed using the Statistical Package for Social Sciences (IBM SPSS Statistic version 25.0). Categorical variables were reported as frequencies and percentages, while continuous variables were reported as means and standard deviations. Patients, tumor, and treatment characteristics were analyzed using chi-square statistics or Fisher's exact test in case of categorical and t-test or analysis of variance (ANOVA) for continuous variables. Survival curves were generated using the Kaplan–Meier method and compared using the log-rank test. Univariable Cox regression analyses were conducted to assess the relationship between the risk of recurrence and death with other prognostic factors. Any variables significant on univariable analysis were included in the multivariable analysis after testing for collinearity. A p-value of less than 0.05 was considered statistically significant.
+ Open protocol
+ Expand
5

Hydroxyurea Efficacy and Safety in Anemia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood transfusion volume, increase in HbF percentage, and the percentage reduction of serum sTfR concentration were compared between hydroxyurea and placebo groups by per-protocol analysis. Adverse events in hydroxyurea and placebo groups were compared by intension-to-treat analysis. Data were analysed using IBM SPSS statistic version 25.0.
+ Open protocol
+ Expand
6

Sentinel Lymph Node Detection Comparison

Check if the same lab product or an alternative is used in the 5 most similar protocols
A false negative SLN was defined as a SLN with negative tumor involvement detected with one SLN mapping technique in combination with a metastatic SLN detected with another SLN mapping technique or a metastatic non-SLN. The SLN detection rate was calculated for each SLN mapping technique, defined as the number of procedures in which at least one SLN was identified divided by the total number of procedures performed. Detection rates among the different subgroups were compared using the chi-square test. Statistical calculations were performed using the Statistical Package for Social Sciences (IBM SPSS Statistic Version 25.0).
In accordance with the journal’s guidelines, we will provide our data for the reproducibility of this study in other centers if this is requested.
+ Open protocol
+ Expand
7

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
All statistical analyses were performed using SPSS Statistic version 25.0 (IBM Corp, Armonk, NY, USA). Categorical variables were expressed as numbers and percentages. Normally distributed data were expressed as mean ± standard deviation, and non-normally distributed data were expressed as median and interquartile range. Cumulative event-free survival was estimated using Kaplan–Meier analyses. p < 0.05 was considered statistically significant.
+ Open protocol
+ Expand
8

Exploratory Data Analysis of Hepatic Failure

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quantitative data are expressed as medians with interquartile ranges (IQR). Categorical variables are given as frequencies and percentages, respectively. Statistical tests included Mann-Whitney-U-Test or Wilson Cox test for unpaired or paired numeric variables, respectively. Chi-square test was performed for nominal values. Our complete data analysis is exploratory. Log-rank test was performed for survival analysis. Here, the one patient was transplanted due to terminal hepatic failure and was not censored in the analysis, being treated as a complete case (death). Hence, no adjustments for multiple testing were performed. For all tests we used a 0.05 level to define statistically relevant deviations from the respective null hypothesis. However, due to the large number of tests, p-values should be interpreted with caution. Data were analysed using IBM SPSS Statistic Version 25.0 (Armonk, NY: IBM Corp.) and GraphPad Prism Version 8.0.2 (GraphPad Software, California, US).
+ Open protocol
+ Expand
9

Evaluating Levetiracetam and Brivaracetam Efficacy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data were analyzed using IBM SPSS Statistic, version 25.0 (IBM Corp., Armonk, NY, USA). For subgroup analyses, baseline characteristics were compared using the Pearson chi-square test for qualitative variables. There was no sample size calculation and all analyses were descriptive. Efficacy and adverse events were calculated using data available from the first and the last follow up. We performed linear trend tests to examine the statistical difference in the response rate for LEV+ and LEV− subgroups, drug-resistant and drug-responsive patients, focal and generalized epilepsy syndromes and changes in seizure frequency correlated to BRV dose. p-Values of <0.05 were considered as significant.
+ Open protocol
+ Expand
10

Survival Analysis of Prognostic Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical calculations were performed using the Statistical Package for Social Sciences (IBM SPSS Statistic Version 25.0). Categorical variables were reported as frequencies and percentages, while continuous variables were reported as means and standard deviations or medians and range. Patient, tumor, and treatment characteristics were analyzed using Chi-square statistics (X 2 ) or Fisher's exact test in case of categorical variables and t-test or analysis of variance (ANOVA) for continuous variables. Survival curves were generated using the Kaplan-Meier method and compared using log-rank test. Univariable Cox regression analyses were conducted to assess the relationship between risk of recurrence or deathand other prognostic factors. Any variables significant in the univariable analysis were included in the multivariable analysis. A P-value of less than 0.05 was considered statistically significant.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!